Showing results (291-300 of 374) with videos related to
Sort By:
Pageof 38
Journal of Virology|August 15, 2014
Stearoyl coenzyme A desaturase 1 is associated with hepatitis C virus replication complex and regulates viral replicationLam N Nguyen, Yun-Sook Lim, Long V Pham, et al.Molecular and Cellular Biology|April 4, 2006
Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinaseSoo-Ho Choi, Kyu-Jin Park, Byung-Yoon Ahn, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1988
Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factorS B Hwang, M H Lam, A W Alberts, et al.Oncogene|August 22, 2012
Pancreatic adenocarcinoma upregulated factor, a novel endothelial activator, promotes angiogenesis and vascular permeabilityS J Kim, Y Lee, N Y Kim, et al.Journal of Virology|November 2, 2018
Hepatitis C Virus Downregulates Ubiquitin-Conjugating Enzyme E2S Expression To Prevent Proteasomal Degradation of NS5A, Leading to Host Cells More Sensitive to DNA DamageHang T Pham, Tram T T Nguyen, Lap P Nguyen, et al.Journal of Virology|March 14, 2003
Interaction with a ubiquitin-like protein enhances the ubiquitination and degradation of hepatitis C virus RNA-dependent RNA polymeraseLu Gao, Hong Tu, Stephanie T Shi, et al.The Journal of Biological Chemistry|August 24, 2016
Hepatitis C Virus Nonstructural 5A Protein Interacts with Abelson Interactor 1 and Modulates Epidermal Growth Factor-mediated MEK/ERK Signaling PathwayVan T T Huynh, Yun-Sook Lim, Si C Tran, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|April 4, 1997
Changes in plasma levels of lipids and lipoprotein composition in patients with Kawasaki diseaseA N Chiang, B Hwang, G C Shaw, et al.The Journal of Biological Chemistry|July 4, 1998
Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein KT Y Hsieh, M Matsumoto, H C Chou, et al.Pharmacological Research|September 1, 2001
Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitorC Qian, S B Hwang, L Libertine-Garahan, et al.Pageof 38